Vrimolol 25 Tablet ER
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Metoprolol Succinate (25mg)
Overview Vrimolol 25 Tablet ER
Cardiolol 25 Extended-Release tablets are a beta-blocker medication indicated for managing hypertension, angina pectoris, and cardiac arrhythmias. This medication also aids in migraine prophylaxis and reducing the risk of future myocardial infarction and cerebrovascular accidents. Cardiolol 25 ER may be administered independently or concurrently with other therapies; dosage and frequency are individualized based on the specific condition and its severity. Administer consistently at the same time daily, either with or without food, for optimal efficacy. Full therapeutic benefit may take several weeks, and continuous use may be necessary. Discontinuation may exacerbate underlying conditions. Commonly reported adverse events include fatigue, cephalalgia, depressive symptoms, diarrhea, dermatological reactions, bradycardia, dizziness, and nausea; these are typically transient and mild. Hypotension and dyspnea are potential, though less frequent, side effects. Gradual dose escalation minimizes adverse effects. Report persistent or bothersome side effects to your physician. Prior to initiation, disclose any hepatic impairment. Cardiolol 25 ER is contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals should consult their physician before use. A thorough discussion with your doctor is vital to determine suitability. Regular blood pressure monitoring ensures treatment effectiveness. Alcohol consumption should be limited due to potential exacerbation of side effects.
Primary Ingredients of Vrimolol 25 Tablet ER
No information provided. A rephrased version cannot be created.
Uses of Vrimolol 25 Tablet ER
Managing angina pectoris (chest discomfort from heart issues)|Correcting cardiac arrhythmias|Reducing the risk of myocardial infarction|Controlling hypertension (elevated blood pressure)|Preventing migraine headaches
Major Benefits of Vrimolol 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Vrimolol 25 Tablet ER whole; do not crush, chew, or break it. While it can be taken with or without food, consistent timing is recommended. For optimal absorption, minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and fatty meats.
Common Side effects of Vrimolol 25 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Vrimolol 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vrimolol 25 Tablet ER whole; do not chew, crush, or divide it. While it can be taken with or without food, consistent timing is recommended. For optimal absorption, avoid consuming Vrimolol 25 Tablet ER with meals high in fat, including items like olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and fatty meats.
How Vrimolol 25 Tablet ER works:
Extended-release Vrimolol 25mg tablets are a cardioselective beta-adrenergic blocker designed to reduce cardiac workload. This is achieved by decreasing heart rate and improving the efficiency of blood circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vrimolol 25 Tablet ER and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vrimolol 25 mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Vrimolol 25 mg tablets appear to be compatible with breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Vrimolol 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Vrimolol 25 mg tablets are considered safe for patients with renal impairment. No alteration in Vrimolol 25 mg ER dosage is necessary.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using extended-release Vrimolol 25 mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vrimolol 25 Tablet ER :
Should you forget a Vrimolol 25 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vrimolol 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |




